Cargando…

Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis

Alternative dosing schedules for licensed human papilloma virus (HPV) vaccines, particularly single dose and extended intervals between doses (>12 months), are being considered to address vaccine shortages and improve operational flexibility. We searched PUBMED/MEDLINE for publications reporting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Secor, Andrew M., Driver, Matthew, Kharono, Brenda, Hergott, Dianna, Liu, Gui, Barnabas, Ruanne V., Dull, Peter, Hawes, Stephen E., Drain, Paul K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712330/ https://www.ncbi.nlm.nih.gov/pubmed/33092049 http://dx.doi.org/10.3390/vaccines8040618

Ejemplares similares

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
por: Hu, Yue-Mei, et al.
Publicado: (2019)

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
por: Donken, Robine, et al.
Publicado: (2016)

Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial
por: Barnabas, Ruanne V., et al.
Publicado: (2021)

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
por: Sankaranarayanan, Rengaswamy, et al.
Publicado: (2016)

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study
por: Romanowski, Barbara, et al.
Publicado: (2015)

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis
por: Staadegaard, Lisa, et al.
Publicado: (2022)

NEW COCHRANE REVIEW ASSESSES DIFFERENT HPV VACCINES AND VACCINE SCHEDULES IN ADOLESCENT GIRLS AND BOYS
Publicado: (2019)

Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis
por: Tan, Darrell H. S., et al.
Publicado: (2020)

HPV vaccination in Kenya: a study protocol to assess stakeholders' perspectives on implementation drivers of HPV vaccination and the acceptability of the reduced dose strategy among providers
por: Umutesi, Grace, et al.
Publicado: (2023)

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity
por: Deloria Knoll, Maria, et al.
Publicado: (2014)

Efficacy of single-dose HPV vaccination among young African women
por: Barnabas, Ruanne V., et al.
Publicado: (2022)

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial
por: Leung, Ting Fan, et al.
Publicado: (2015)

The one-dose schedule opens the door to rapid scale-up of HPV vaccination
por: Zou, Zhuoru, et al.
Publicado: (2023)

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial
por: Huang, Li-Min, et al.
Publicado: (2017)

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
por: Bergman, Hanna, et al.
Publicado: (2019)

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
por: Barnabas, Ruanne V, et al.
Publicado: (2006)

Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule
por: Shadab, Ruha, et al.
Publicado: (2021)

Demographic and risk group heterogeneity across the UNAIDS 90-90-90 targets: a systematic review and meta-analysis protocol
por: Green, Dylan, et al.
Publicado: (2019)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9–11 year-old girls and boys – clinical protocol
por: Zeng, Yi, et al.
Publicado: (2019)

Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90‐90‐90 in sub‐Saharan Africa – a systematic review and meta‐analysis
por: Green, Dylan, et al.
Publicado: (2020)

Incremental costs of integrated PrEP provision and effective use counselling in community‐based platforms for adolescent girls and young women in South Africa: an observational study
por: Mudimu, Edinah, et al.
Publicado: (2022)

HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
por: Celum, Connie L, et al.
Publicado: (2019)

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
por: Canfell, Karen, et al.
Publicado: (2019)

Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact
por: Gilca, Vladimir, et al.
Publicado: (2018)

A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination
por: Batmunkh, Tsetsegsaihan, et al.
Publicado: (2020)

Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
por: Rungmaitree, Supattra, et al.
Publicado: (2022)

Immunogenicity of a 5‐dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022)

Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth
por: Rovithi, Maria, et al.
Publicado: (2016)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Tolerability of Alternative Dosing Schedules for Sunitinib: A Systematic Review and Meta-Analysis
por: Kang, Hee Jung, et al.
Publicado: (2020)

Immunogenicity of two different hepatitis B vaccine schedules
por: Agladioglu, S. Y., et al.
Publicado: (2011)

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
por: Schwarz, Tino F., et al.
Publicado: (2019)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Preparedness of Young Girls for Prevention of Cervical Cancer and Strategy to introduce the HPV Vaccine
por: Swain, Dharitri, et al.
Publicado: (2018)

Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya
por: Wanga, Valentine, et al.
Publicado: (2021)

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2018)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vsao1otq38ssspei2v71e1egat